Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorazepam dose effects on 7.5% carbon dioxide-induced anxiety model
2006-001085-17Phase 4Completed
- Sponsor
- University of Bristol
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of lorazepam in generalized anxiety disorder (GAD) (3 arms), sponsored by University of Bristol. Started Jun 2007; status: completed.
02
Drugs
lorazepam
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on 2006-001085-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001085-17.